Literature DB >> 29582643

Chemopreventive Effects of Edible Canna (Canna edulis Kerr.) Against Colorectal Carcinogenesis: Effects on Expression of Adenomatous Polyposis Coli and Inducible Nitric Oxide Synthase in Rat Inflammatory Model

Nur Mahmudah, Sitarina Widyarini, Dewajani Purnomosari.   

Abstract

Objective: Dietary high fibre and calcium intake has been suggested to reduce colorectal cancer risk. However, there is limited information available regarding the potential of edible canna (Ganyong), with high dietary fibre and calcium content, to act as a preventive agent for colorectal cancer. This experimental study was conducted to investigate the preventive effect of Ganyong in reducing colorectal carcinogenesis with attention to effects on adenomatous polyposis coli (APC) and inducible nitric oxide synthase (iNOS) expression.
Methods: Thirty male Wistar rats were divided into 5 equal groups; a normal control group without azoxymethane/dextran sodium sulphate (AOM/DSS) induction and Ganyong, a ‘cancer’ control group with AOM/DSS induction only, and three treatment groups with AOM/DSS induction and different percentages (5%, 10% and 20%) of Ganyong. Paraffin-embedded sections of rat colon tissue were analysed by haematoxylin-eosin and immunohistochemical staining against antibodies against APC and iNOS. Variation in rates of APC and iNOS expression were analyzed using the Kruskal-Wallis test followed by the Dunn’s test (SPSS statistic version 24). P<0.05 was considered statistically significant.
Results: AOM/DSS induction increased the expression of APC (p=0.013) and iNOS (p=0.013) compared to the normal control group. APC expression in the treated groups was lower than in the ‘cancer’ control group (p=0.049), especially in the 10% Ganyong group (p=0.02). In contrast, there was no significant variation among the treated groups regarding iNOS expression. Histopathological features of the colon supported the data for APC and iNOS expression.
Conclusion: This study indicated potential chemopreventive effects of Ganyong reducing expression of factors contributing to colorectal carcinogenesis. Creative Commons Attribution License

Entities:  

Keywords:  Canna edulis; adenomatous polyposis coli; inducible nitric oxide synthase; colorectal cancer

Mesh:

Substances:

Year:  2018        PMID: 29582643      PMCID: PMC5980864          DOI: 10.22034/APJCP.2018.19.3.839

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


Introduction

Colorectal cancer (CRC) is one of the Indonesian major health issues causing approximately 15.1 age-standardised mortality per 100,000 population a year (Ferlay et al., 2015). The aetiology of sporadic CRC is predominately rooted by dietary and lifestyle behaviours. Some studies revealed that high dietary intake of fibre and calcium have been associated with lower CRC risk (Haggar and Boushey, 2009; Murphy et al., 2012; Ahearn et al., 2012). Edible canna or Ganyong (Canna edulis Kerr., family Cannaceae) is a crude herbaceous flowering plant with large small banana-like leave. It has a bright yellow, orange or red coloured flower. It grows from large, thick and underground rootstock that form a tuber and about 90 centimetres to 3 meters tall. This tuber contains various phytochemicals that has been used in traditional medicine for the treatment of many complaints. It also has high dietary fibre and calcium content (Al-Snafi, 2015). However, there was limited available information regarding the role of Ganyong as CRC preventing agent. Dietary fibre has a protective effect against CRC by increasing faecal bulking, reducing inflammation and shortening the contact time between the carcinogenic agent and the gut (Lima and Gomes-da-Silva, 2005; Suckow et al., 2006; Kaczmarczyk et al., 2012). During the digestion process, the dietary fibre could be transformed to butyrate towards fermentation. Butyrate acts as histone deacetylase inhibitors agent (HDACi); a mechanism by which not only reducing proliferation and β-catenin expression but also increasing apoptosis and Adenomatous Polyposis Coli (APC) expression (Bordonaro at al., 2011; Zhao et al., 2014). In accordance, calcium reduces inflammation, β-catenin and increases E-cadherin, MutL Homolog 1 (MLH1) and MutS Homolog 2 (MLH2) expression (Sidelnikov et al., 2010; Yang et al., 2014). Azoxymethane (AOM) is a carcinogenic compound. The combination of AOM and dextran sodium sulphate (DSS) has been widely used for CRC induction in vivo study. The pathogenesis of AOM/DSS-induced CRC often linked to APC and Inducible Nitric Oxide Synthase (iNOS). Adenomatous Polyposis Coli inhibits β-catenin thus reduces cell proliferation while iNOS acts as an inflammatory agent that can initiate tumour-associated inflammation (Saad et al., 2012; Chen et al., 2013). The aim of this study was to evaluate the role of APC and iNOS expression in AOM/DSS-induced rat treated with Ganyong.

Materials and Methods

Materials

Fresh Ganyong’s (Canna edulis Kerr.) tubers were supplied by local producers from Sukoharjo, Indonesia. A specimen voucher was deposited at herbarium unit in Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia. Samples were prepared by drying thick chips of the tubers in an oven (30 °C, 40 h). Subsequently, these dried chips were milled to produce powdered flours. The powdered Ganyong tubers were consumed as a food supplement.

Subject description

Thirty male Wistar rats were divided into 5 equal groups: (1) the control group, (2) positive control cancer group with AOM/DSS induction only, (3) treated with 5% Ganyong, (4) treated with 10% Ganyong and (5) treated with 20% Ganyong. Single 10 mg/kg BW dose of AOM in 10% buffer saline was given intraperitoneally to non-normal group in the fourth week of the experiment. Animals were also administered 2% DSS drink in the week of the experiment. Wistar rats were obtained from Cancer Research Centre Laboratory, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia. All animals were placed individually and maintained under standard conditions of temperature (25 ± 1.0 °C), humidity (55 ± 10%), 12-h light/dark cycle with free access of rat’s standard food (Comfeed Industries Ltd) and water ad libitum. All equipment that were included in handling and sacrificing were in accordance to European Council Legislation for The Protection of Experimental Animals. All of the animal treatment procedures were approved by Medical and Health Research Ethics Committee (Faculty of Medicine, Universitas Gadjah Mada), decision number KE/FK/557/EC.

Tissue processing

After 14 weeks of treatment, colon tissue of Wistar rats were collected and embedded in paraffin wax using Swiss roll technique (Colnot et al., 2004). Sections were sliced for 5 and 4 µm of thickness used for histological and immunohistochemical staining respectively.

Histological staining

Five-micron paraffin sections were stained with Haematoxylin-Eosin for examining morphological changes of colon tissue according to previous study (Bourroul et al., 2013).

Immunohistochemical staining of APC and iNOS

Primary antibody anti-APC (Biorbyt, orb10109) 0.5 mg/ml and anti-iNOS (ABCAM, ab15323) 0.052 mg/ml in buffer saline were used in this study. Immunostaining was performed using Starr Trek™ Universal HRP Detection System kit (Biocare, Concord, CA, USA) at room temperature according to the manufacturer instruction. Peroxidase activity were detected by incubating samples with 3,3 Diaminobenzedine (DAB) chromogen substrate. It considered positive when there is a formation of a brown precipitate. Finally, sections were counterstained with haematoxylin and DPX mounted.

Evaluation of immunohistochemical staining

For evaluation, five and seven areas of each APC and iNOS section were selected randomly in 400X magnification, respectively. Each area was observed by two blinded observers. Data were collected from the modified proportion (Bourroul et al., 2013) sum of positive cell per total cell in the same area with given formula: Proportion = (Total positive cells/ Total cells) x 100%

Data analysis

The data were shown in median (minimum-maximum) proportion. Data were collected from the mean of 5 and 7 images for APC and iNOS expression respectively. Normality test used Saphiro-Wilk test. APC and iNOS expression were tested by Kruskal-Wallis test followed by Dunn’s test for group comparison. A median difference considered significant when p<0.05 (SPSS statistics version 24).

Results

Histopathological Status of Rat Colon

Thirty paraffin sections of colon tissue from 30 male Wistar rats were used in this research. The histopathological status of CRC was divided into normal, colitis, dysplasia and adenocarcinoma and established under experienced pathologist supervision (Bourroul et al., 2013). Histopathological status of rat colon was summarized in Table 1.
Table 1

The Profile of APC and iNOS Expression among Groups

GroupsnHistophatology (%)APC ExpressioniNOS Expression
Normal6Normal100No expressionNo expression
AOM/DSS6Normal16.7No expressionNo expression
Colitis33.3Cytoplasmic staining of stromalCytoplasmic staining of stromal
Dysplasia33.3Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cellCytoplasmic staining of tumour cell
Adenocarcinoma16.7Cytoplasmic staining of epithelial and tumour cellCytoplasmic staining of tumour cell
5% treated Ganyong6Normal16.7No expressionNo expression
Colitis33.3Cytoplasmic staining of stromalCytoplasmic staining of stromal
Dysplasia16.7Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cellCytoplasmic staining of tumour cell
Adenocarcinoma33.3Cytoplasmic staining of epithelial and tumour cellCytoplasmic staining of tumour cell
10% treated Ganyong6Normal50No expressionNo expression
Colitis33.3Cytoplasmic staining of stromalCytoplasmic staining of stromal
Dysplasia16.7Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cellCytoplasmic staining of tumour cell
20% treated Ganyong6Normal33.3No expressionNo expression
Colitis33.3Cytoplasmic staining of stromalCytoplasmic staining of stromal
Dysplasia16.7Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cellCytoplasmic staining of tumour cell
Adenocarcinoma16.7Cytoplasmic staining of epithelial and tumour cellCytoplasmic staining of tumour cell
The Profile of APC and iNOS Expression among Groups

Effect of Ganyong on APC and iNOS expressions

Both APC and iNOS were not expressed in normal control group. Meanwhile, APC was expressed in stromal, epithelial and tumour cells whereas iNOS was expressed in stromal and tumour cells (Figure 1) in non-normal control groups. The immunohistochemical staining profile of APC and iNOS were summarised in Table 1.
Figure 1

Haematoxylin-Eosin and Immunohistochemical Staining of Colon Tissue in 400X Magnification. The histopathological of colon was considered as normal, colitis, dysplasia and adenocarcinoma (a-c). APC localisation was shown in stromal, stromal-epithelial border, epithelial and tumour cells (d-f). iNOS localisation was shown in stromal and epithelial cells (g-i). Normal colon (a) was not expressed APC (d) and iNOS (g). Colitis colon (b) expressed APC and iNOS in the cytoplasm of stromal. Dysplasia and adenocarcinoma colon (c) expressed APC in the cytoplasm of stromal, stromal-epithelial border and epithelial cells (f), and expressed iNOS in tumour cell, whereas iNOS expression was in the cytoplasm of tumour cell (g).

Haematoxylin-Eosin and Immunohistochemical Staining of Colon Tissue in 400X Magnification. The histopathological of colon was considered as normal, colitis, dysplasia and adenocarcinoma (a-c). APC localisation was shown in stromal, stromal-epithelial border, epithelial and tumour cells (d-f). iNOS localisation was shown in stromal and epithelial cells (g-i). Normal colon (a) was not expressed APC (d) and iNOS (g). Colitis colon (b) expressed APC and iNOS in the cytoplasm of stromal. Dysplasia and adenocarcinoma colon (c) expressed APC in the cytoplasm of stromal, stromal-epithelial border and epithelial cells (f), and expressed iNOS in tumour cell, whereas iNOS expression was in the cytoplasm of tumour cell (g). The strongest expression of APC and iNOS were observed in cancer control group and it was significantly different compared to normal control group (p=0.01). Treated groups showed significantly lower expression of APC than cancer control (p=0.05), especially in the 10% Ganyong group (p=0.02). In contrast, there were no significant differences among all treated groups for iNOS expression compared to cancer control group. The result of Kruskal-Wallis test of both APC and iNOS expression can be seen in Table 2.
Table 2

Expression of APC and iNOS in Colonic Rat Tissue

GroupsnAPCiNOS
Expression (%)p valueExpression (%)p value
Normal60 (0–0.02)aP=0.010 (0–0.394)cP=0.01
AOM/DSS60.23 (0–0.68)a,b1.11 (0–9.74)c
5% Treated Ganyong60.03 (0–0.34)0.2 (0–2.13)
10% Treated Ganyong60 (0–0.05)bp=0.021.57 (0–3.34)
20% Treated Ganyong60 (0–0.5)0.29 (0–1.67)

Data distribution test with Saphiro-Wilk, p<0.05. Data showed in median (minimum-maximum); Kruskal-Wallis tests significant, p<0.05. Dunn’s test with significant result are marked with a superscript notation; a,b,c different subscript value in the same column indicates significant difference (p<0.05).

Expression of APC and iNOS in Colonic Rat Tissue Data distribution test with Saphiro-Wilk, p<0.05. Data showed in median (minimum-maximum); Kruskal-Wallis tests significant, p<0.05. Dunn’s test with significant result are marked with a superscript notation; a,b,c different subscript value in the same column indicates significant difference (p<0.05).

Discussion

The combination of AOM and DSS is commonly used for colon cancer induction in rodent model due to its fast and specific carcinogenic effect (Rosenberg et al., 2009; De Robertis et al., 2011; Zhao et al., 2014). Dextran Sodium Sulphate, an acute inflammatory agent, causes temporary epithelial damage, while the combination of AOM/DSS treatment leads to persistent inflammation (Schultz et al., 2004; Tanaka, 2012; Zeineldin et al., 2014). Furthermore, this combination induces APC mutation and nuclear β-catenin localisation leading to carcinogenesis. The localisation of nuclear β-catenin is correlated with iNOS expression (Takahashi et al., 2000; Neufert et al., 2007). Similar to previous studies, the present study demonstrated a significant difference of APC and iNOS expression between control group and AOM/DSS-induced group (cancer control group). Generally, the expression of APC in Ganyong treated group was lower than cancer control group. However, the significant difference was only found in the group treated with 10% of Ganyong. The decreasing of CRC-incidence due to high dietary fibre intake was reported before (Chen et al., 2004). Butyrate, the major short chain fatty acid (SCFA) produced from Ganyong’s fibre fermentation, was able to inhibit the colorectal carcinogenesis and lowering the CRC risk (Chiaro et al., 2012). It modified any cellular processes through the activation of G-protein couple receptors (GPCRs), HDACi, stimulating the histone acyl transferase and stabilising hypoxia-inducible factor (HIF) (Corrêa-Oliviera et al., 2016). Butyrate also induced p21 expression and inhibited cancer cell proliferation (Chen et al., 2004). However, the fibre must reach the gut then fermented to produce SCFA to be functional as anti-carcinogenic agent (Toden et al., 2014). The role of microbial gut was also important in order to increase the rate of fermentation (Louis et al., 2014). On the other hand, butyrate from Anaerostipes hadrus BPB5 fermentation aggravated the colitis by increasing lipopolysaccharide producer (Zhang et al., 2015). The dose dependent effect of Ganyong administration was implied in this study. The elevation of Ganyong administration decreased the mutant APC expression due to the increasing of butyrate fermentation rate (Chen et al., 2004). Nonetheless, the expression of APC in 20% Ganyong treated groups was tended to increase. It was assumed that the overproduction of butyrate might have led to butyrate resistance phenomenon (Garland et al., 2006). The cell resisted the anti-proliferative effect of HDACi from butyrate (Bordonaro et al., 2011). Moreover, the anti-proliferative effect has not been expressed by all types of butyrate. Iso-butyrate was reported to have a proliferative effect (Chen et al., 2004). Ganyong is reported as a good source of calcium. One thousand eight hundred mg of calcium per day is needed to prevent CRC (Chiaro et al., 2011). Calcium was known as an anti-inflammatory agent through its binding to the bile acids. The present study showed that calcium only binds bile acids specifically from fat intake (Fedirko et al., 2015). Besides being as an anti-inflammatory agent, calcium also plays an important role as a cofactor. This study showed that the expression of iNOS was not significantly different between treated groups and cancer control group. Since iNOS are non-dependent-calcium enzyme (Kiemer and Vollmar, 2001), the non-significant effect of Ganyong in iNOS expression was reasonable. This research only indicated the correlation between the elevation of mutant APC expression with bad prognosis. It detected in the colitis and increased along the transformation of histopathological status (Figure 1). Previous studies revealed that APC mutation could transformed normal epithelial cell to microadenoma, an early sign of dysplastic condition sequence of adenoma or adenocarcinoma (Fodde et al., 2001; Yamada and Mori, 2007; Harpaz and Polydorides, 2010). Moreover, the restoration of APC re-established the crypt homeostasis (Dow et al., 2015) was assumed that mutant APC expression could be used as a pre-neoplastic biomarker. The present study shows that calcium and dietary fibre-rich Ganyong has been proved in reducing the CRC risk. Dietary fibre and calcium acts as anti-proliferative agent by reducing mutant APC expression. This present study highlighted the potency of Ganyong as chemopreventive agent for CRC through downregulating of mutant APC.

List of Abbreviations

AOM: Azoxymethane APC: Adenomatous polyposis coli BPB5: Butyrate-producing bacteria 5 CRC: Colorectal cancer DSS: Dextran sodium sulphate GPCRs: G-protein couple receptors HDACi: Histone deacetylase inhibitors HIF: Hypoxia-inducible factors iNOS: Inducible nitric oxide synthase MLH1: MutL homolog 1 MLH2: MutS homolog 2 SCFA: Short chain fatty acids

Funding Statement

The research was funded by a grant scholarship from the ministry of Research, Technology and Higher Education of Republic of Indonesia (BPPDN-DIKTI 2013).
  32 in total

1.  Suppression of β-catenin and cyclooxygenase-2 expression and cell proliferation in azoxymethane-induced colonic cancer in rats by rice bran phytic acid (PA).

Authors:  Norazalina Saad; Norhaizan Mohd Esa; Hairuszah Ithnin
Journal:  Asian Pac J Cancer Prev       Date:  2013

Review 2.  Calcium and vitamin D. Their potential roles in colon and breast cancer prevention.

Authors:  C F Garland; F C Garland; E D Gorham
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

3.  Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial.

Authors:  Veronika Fedirko; Roberd M Bostick; Qi Long; W Dana Flanders; Marjorie L McCullough; Eduard Sidelnikov; Carrie R Daniel; Robin E Rutherford; Aasma Shaukat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

4.  Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.

Authors:  Christopher Chiaro; Darina L Lazarova; Michael Bordonaro
Journal:  Biochem Biophys Res Commun       Date:  2012-10-11       Impact factor: 3.575

Review 5.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

6.  Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice.

Authors:  Maged Zeineldin; Matthew A Miller; Ruth Sullivan; Kristi L Neufeld
Journal:  Carcinogenesis       Date:  2014-06-03       Impact factor: 4.944

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

Authors:  Mariangela De Robertis; Emanuela Massi; Maria Luana Poeta; Simone Carotti; Sergio Morini; Loredana Cecchetelli; Emanuela Signori; Vito Michele Fazio
Journal:  J Carcinog       Date:  2011-03-24

9.  Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.

Authors:  Lukas E Dow; Kevin P O'Rourke; Janelle Simon; Darjus F Tschaharganeh; Johan H van Es; Hans Clevers; Scott W Lowe
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

10.  Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC).

Authors:  Neil Murphy; Teresa Norat; Pietro Ferrari; Mazda Jenab; Bas Bueno-de-Mesquita; Guri Skeie; Christina C Dahm; Kim Overvad; Anja Olsen; Anne Tjønneland; Françoise Clavel-Chapelon; Marie Christine Boutron-Ruault; Antoine Racine; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Manuela M Bergmann; Antonia Trichopoulou; Dimitrios Trichopoulos; Pagona Lagiou; Domenico Palli; Valeria Pala; Salvatore Panico; Rosario Tumino; Paolo Vineis; Peter Siersema; Franzel van Duijnhoven; Petra H M Peeters; Anette Hjartaker; Dagrun Engeset; Carlos A González; Maria-José Sánchez; Miren Dorronsoro; Carmen Navarro; Eva Ardanaz; José R Quirós; Emily Sonestedt; Ulrika Ericson; Lena Nilsson; Richard Palmqvist; Kay-Tee Khaw; Nick Wareham; Timothy J Key; Francesca L Crowe; Veronika Fedirko; Petra A Wark; Shu-Chun Chuang; Elio Riboli
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.